×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
1165 views

Modérateur : Fabrice Lécuru

Au programme de cette soirée

18:00 Introduction
Fabrice Lécuru
 
18:05 A qui doit-on proposer une intervention chirurgicale ?
Gwenaël Ferron
 
18:30 Que faire pour les tumeurs rares ?
Fabrice Lécuru
 
18:55 Quelles options médicales pour une rechute platine sensible ?
Mathilde Saint-Ghislain
 
19:20 Débat/Discussion et réponses aux questions
 

 

Shooting date : 2022-12-08
Last update : 2023-05-17
1 comment
Join the Discussion
  • Olfa B. En cas de scores ago et imodel discordants, lequel utiliser pour decider de faire ou non la chirurgie ?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, September 15th 2021 from 06pm to 07:30pm (GMT+2)
    Honolulu : Wednesday, September 15th 2021 from 06am to 07:30am (GMT-10)
    San Francisco : Wednesday, September 15th 2021 from 09am to 10:30am (GMT-7)
    New York : Wednesday, September 15th 2021 from 12pm to 01:30pm (GMT-4)
    Buenos Aires : Wednesday, September 15th 2021 from 01pm to 02:30pm (GMT-3)
    Reykjavik : Wednesday, September 15th 2021 from 04pm to 05:30pm (GMT)
    London / Dublin : Wednesday, September 15th 2021 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, September 15th 2021 from 06pm to 07:30pm (GMT+2)
    Istanbul : Wednesday, September 15th 2021 from 07pm to 08:30pm (GMT+3)
    Moscou / Dubaï : Wednesday, September 15th 2021 from 08pm to 09:30pm (GMT+4)
    Bangkok : Wednesday, September 15th 2021 from 11pm to 12:30am (GMT+7)
    Shanghai : Thursday, September 16th 2021 from 12am to 01:30am (GMT+8)
    Tokyo : Thursday, September 16th 2021 from 01am to 02:30am (GMT+9)
    Sydney : Thursday, September 16th 2021 from 03am to 04:30am (GMT+11)
    Wellington : Thursday, September 16th 2021 from 05am to 06:30am (GMT+13)

    Comment passer des recommandations de Saint-Paul-de-Vence à la pratique quotidienne ?

    La prise en charge du cancer avancé de l'ovaire

    Share
    Tuesday, June 22nd 2021 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, June 22nd 2021 from 06:30am to 08am (GMT-10)
    San Francisco : Tuesday, June 22nd 2021 from 09:30am to 11am (GMT-7)
    New York : Tuesday, June 22nd 2021 from 12:30pm to 02pm (GMT-4)
    Buenos Aires : Tuesday, June 22nd 2021 from 01:30pm to 03pm (GMT-3)
    Reykjavik : Tuesday, June 22nd 2021 from 04:30pm to 06pm (GMT)
    London / Dublin : Tuesday, June 22nd 2021 from 05:30pm to 07pm (GMT+1)
    Paris / Berlin : Tuesday, June 22nd 2021 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, June 22nd 2021 from 07:30pm to 09pm (GMT+3)
    Moscou / Dubaï : Tuesday, June 22nd 2021 from 08:30pm to 10pm (GMT+4)
    Bangkok : Tuesday, June 22nd 2021 from 11:30pm to 01am (GMT+7)
    Shanghai : Wednesday, June 23rd 2021 from 12:30am to 02am (GMT+8)
    Tokyo : Wednesday, June 23rd 2021 from 01:30am to 03am (GMT+9)
    Sydney : Wednesday, June 23rd 2021 from 03:30am to 05am (GMT+11)
    Wellington : Wednesday, June 23rd 2021 from 05:30am to 07am (GMT+13)

    Cancer de l’ovaire en rechute platine sensible : évolution de la PEC et impact sur la survie glob...

    Share
    Monday, November 28th 2022 from 06pm to 07:30pm (GMT+2)
    Honolulu : Monday, November 28th 2022 from 06am to 07:30am (GMT-10)
    San Francisco : Monday, November 28th 2022 from 08am to 09:30am (GMT-8)
    New York : Monday, November 28th 2022 from 11am to 12:30pm (GMT-5)
    Buenos Aires : Monday, November 28th 2022 from 01pm to 02:30pm (GMT-3)
    London / Dublin : Monday, November 28th 2022 from 04pm to 05:30pm (GMT)
    Paris / Berlin : Monday, November 28th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Monday, November 28th 2022 from 06pm to 07:30pm (GMT+2)
    Moscou / Dubaï : Monday, November 28th 2022 from 08pm to 09:30pm (GMT+4)
    Bangkok : Monday, November 28th 2022 from 11pm to 12:30am (GMT+7)
    Shanghai : Tuesday, November 29th 2022 from 12am to 01:30am (GMT+8)
    Tokyo : Tuesday, November 29th 2022 from 01am to 02:30am (GMT+9)
    Sydney : Tuesday, November 29th 2022 from 02am to 03:30am (GMT+10)
    Wellington : Tuesday, November 29th 2022 from 04am to 05:30am (GMT+12)

    Prise en charge du cancer de l’ovaire avancé à l’ère de la médecine de précision en 2022

    Share
    Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, January 31st 2023 from 06am to 07:30am (GMT-10)
    San Francisco : Tuesday, January 31st 2023 from 08am to 09:30am (GMT-8)
    New York : Tuesday, January 31st 2023 from 11am to 12:30pm (GMT-5)
    Buenos Aires : Tuesday, January 31st 2023 from 01pm to 02:30pm (GMT-3)
    London / Dublin : Tuesday, January 31st 2023 from 04pm to 05:30pm (GMT)
    Paris / Berlin : Tuesday, January 31st 2023 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, January 31st 2023 from 06pm to 07:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, January 31st 2023 from 08pm to 09:30pm (GMT+4)
    Bangkok : Tuesday, January 31st 2023 from 11pm to 12:30am (GMT+7)
    Shanghai : Wednesday, February 1st 2023 from 12am to 01:30am (GMT+8)
    Tokyo : Wednesday, February 1st 2023 from 01am to 02:30am (GMT+9)
    Sydney : Wednesday, February 1st 2023 from 02am to 03:30am (GMT+10)
    Wellington : Wednesday, February 1st 2023 from 04am to 05:30am (GMT+12)

    Cancer de l'ovaire en 1L :

    Actualités et options thérapeutiques disponibles en 2023

    Share
    Scroll Up